• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·002172.SZ
Share

Jiangsu Aoyang Health Industry Co.ltd. Stocks

CN¥ 3.37Last Updated 28.05.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 375.06M

CN¥ 3.37
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Jiangsu Aoyang Health Industry Co.ltd. produces and sells chemical fibers in China and internationally. It offers various functional fibers, as well as conventional viscose fibers. The company also operates hospitals, rehabilitation centers, and pharmaceutical retail chains. In addition, it offers health management and pharmaceutical logistics, as well as distributes pharmaceutical products. The company was formerly known as Jiangsu Aoyang Technology Corporation Limited. and changed its name to Jiangsu Aoyang Health Industry Co.ltd. in September 2018. Jiangsu Aoyang Health Industry Co.ltd. was founded in 2001 and is based in Zhangjiagang, China.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA, trading a

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 002172.SZ is 5.1 and suggests 51% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.05.2026 03:57

One of the most popular cryptocurrencies in the world is entering the US market

30.05.2026 03:28

Barclays expects a turnaround in lagging sectors. Which stocks are likely to win?

30.05.2026 02:40

Kazakhstan can accept Iranian uranium reserves - IAEA head

30.05.2026 01:28

U.S. stocks posted their ninth consecutive week of gains. This has not happened in three years

30.05.2026 00:56

Space stocks collapse after Blue Origin rocket explosion and SpaceX valuation drop

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026